The concept that myeloablation to open space was a prerequisite for ma
rrow stem cell engraftment has been challenged by studies showing high
rates of engraftment in nonmyeloablated mice (Stewart et al, Blood 81
:2566, 1993; Quesenberry et al, Blood Cells 20:97, 1994; Brecher et al
, Blood Cells 5:237, 1979; Saxe et al, Exp Hematol 12:277, 1984; and W
u et al, Exp Hematol 21:251, 1993). However, relatively large numbers
of marrow cells were necessary to achieve high long-term donor percent
ages. We have demonstrated, using a BALB/c male/female marrow transpla
nt model and detecting male DNA in host tissues by Southern blot or fl
uorescent in situ hybridization, that exposure to doses of irradiation
that cause minimal myeloablation (50 to 100 cGy) leads to very high l
evels of donor chimerism, such that relatively small numbers of marrow
cells (10 to 40 million) can give donor chimerism in the 40% to 100%
range. Studies of radiation sensitivity of long-term engrafting cells
have shown that 100 cGy, although not myelotoxic, is stem cell toxic,
and indicate that the final host:donor ratios are determined by compet
ition between host and donor stem cells. These data indicate that low
levels of irradiation should be an effective approach to nontoxic marr
ow transplantation in gene therapy or in attempts to create allochimer
ism to treat such diseases as cancer, sickle cell anemia, or thalassem
ia. (C) 1998 by The American Society of Hematology.